“Calcium Channel Blockers May Decrease COVID-19 Susceptibility in Europeans, Study Suggests”

https://pubmed.ncbi.nlm.nih.gov/38116083

This study suggests that calcium channel blockers (CCBs) may reduce the susceptibility to COVID-19 in European populations, based on a drug-target Mendelian randomization analysis.